Impact ledger
Sage Therapeutics, Inc. (SAGE)
4 events mapped to this ticker since 2026-06-22.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-29 | Event | Indirect competitive pressure or validation of gene therapy approach for neurological disorders. While not directly competitive for Rett Syndrome, success in gene therapy for neurological conditions can influence investor sentiment across the sub-sector. | watch | 1-3m | 0.30 |
| 2026-06-29 | Event | Indirect competitive pressure or market validation for gene therapies targeting neurological disorders, specifically Rett syndrome. | watch | 3-12m | 0.30 |
| 2026-06-22 | Event | Indirect competitive pressure in the neurological disorder space, particularly for rare diseases affecting children. | watch | 3-12m | 0.30 |
| 2026-06-22 | Event | While not directly competitive with TSHA-102, success in gene therapy for neurological disorders like Rett syndrome could validate the broader market for advanced therapies in this space, potentially attracting more investment and research, which could indirectly benefit other companies developing t | watch | 1-5y | 0.30 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for SAGE, start a trial or view the SAGE entity page.